Literature DB >> 17317095

In utero arsenic exposure induces early onset of atherosclerosis in ApoE-/- mice.

Sanjay Srivastava1, Stanley E D'Souza, Utpal Sen, J Christopher States.   

Abstract

Consumption of arsenic contaminated drinking water has been linked to higher rates of coronary disease, stroke, and peripheral arterial disease. Recent evidence suggests that early life exposures may play a significant role in the onset of chronic adult diseases. To investigate the potential for in utero arsenic exposure to accelerate the onset of cardiovascular disease we exposed pregnant ApoE-knockout (ApoE(-/-)) mice to arsenic in their drinking water and examined the aortic trees of their male offspring for evidence of early disease 10 and 16 weeks after birth. Mice were maintained on normal chow after weaning. ApoE(-/-) mice are a commonly used model for atherogenesis and spontaneously develop atherosclerotic disease. Mice exposed to arsenic in utero showed a >2-fold increase in lesion formation in the aortic roots as well as the aortic arch compared to control mice at both 10 and 16 weeks of age. The mice exposed to arsenic also had a 20-40% decrease in total triglycerides, but no change in total cholesterol, phospholipids and total abundance of VLDL or HDL particles. Subfractionation of VLDL particles showed a decrease in large VLDL particles. In addition, the arsenic-exposed mice showed a vasorelaxation defect in response to acetylcholine suggesting disturbance of endothelial cell signalling. These results indicate that in utero arsenic exposure induces an early onset of atherosclerosis in ApoE(-/-) mice without a hyperlipidemic diet and support the hypothesis that in utero arsenic exposure may be atherogenic in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17317095      PMCID: PMC1963457          DOI: 10.1016/j.reprotox.2007.01.005

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  55 in total

1.  Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia.

Authors:  J Pi; Y Kumagai; G Sun; H Yamauchi; T Yoshida; H Iso; A Endo; L Yu; K Yuki; T Miyauchi; N Shimojo
Journal:  Free Radic Biol Med       Date:  2000-04-01       Impact factor: 7.376

2.  Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease.

Authors:  Moo-Yeol Lee; Ok-Nam Bae; Seung-Min Chung; Kyu-Tae Kang; Joo-Young Lee; Jin-Ho Chung
Journal:  Toxicol Appl Pharmacol       Date:  2002-03-01       Impact factor: 4.219

Review 3.  Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.

Authors:  K T Kitchin
Journal:  Toxicol Appl Pharmacol       Date:  2001-05-01       Impact factor: 4.219

Review 4.  Mouse models of hyperlipidemia and atherosclerosis.

Authors:  S Fazio; M F Linton
Journal:  Front Biosci       Date:  2001-03-01

5.  Biological gradient between long-term arsenic exposure and carotid atherosclerosis.

Authors:  Chih-Hao Wang; Jiann-Shing Jeng; Ping-Keung Yip; Chi-Ling Chen; Lin-I Hsu; Yu-Mei Hsueh; Hung-Yi Chiou; Meei-Mann Wu; Chien-Jen Chen
Journal:  Circulation       Date:  2002-04-16       Impact factor: 29.690

6.  Arsenic poisoning in groundwater: health risk and geochemical sources in Bangladesh.

Authors:  H M Anawar; J Akai; K M G Mostofa; S Safiullah; S M Tareq
Journal:  Environ Int       Date:  2002-02       Impact factor: 9.621

7.  Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis.

Authors:  Melisa Bunderson; Diane M Brooks; David L Walker; Michael E Rosenfeld; J Douglas Coffin; Howard D Beall
Journal:  Toxicol Appl Pharmacol       Date:  2004-11-15       Impact factor: 4.219

Review 8.  The cellular metabolism and systemic toxicity of arsenic.

Authors:  D J Thomas; M Styblo; S Lin
Journal:  Toxicol Appl Pharmacol       Date:  2001-10-15       Impact factor: 4.219

9.  Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan.

Authors:  M M Wu; H Y Chiou; T W Wang; Y M Hsueh; I H Wang; C J Chen; T C Lee
Journal:  Environ Health Perspect       Date:  2001-10       Impact factor: 9.031

10.  Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis.

Authors:  Hua Chen; ShuanFang Li; Jie Liu; Bhalchandra A Diwan; J Carl Barrett; Michael P Waalkes
Journal:  Carcinogenesis       Date:  2004-04-08       Impact factor: 4.944

View more
  28 in total

1.  Exposure to moderate arsenic concentrations increases atherosclerosis in ApoE-/- mouse model.

Authors:  Maryse Lemaire; Catherine A Lemarié; Manuel Flores Molina; Ernesto L Schiffrin; Stéphanie Lehoux; Koren K Mann
Journal:  Toxicol Sci       Date:  2011-04-21       Impact factor: 4.849

2.  In utero arsenic exposure and epigenome-wide associations in placenta, umbilical artery, and human umbilical vein endothelial cells.

Authors:  Andres Cardenas; E Andres Houseman; Andrea A Baccarelli; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mostofa; Robert O Wright; David C Christiani; Molly L Kile
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

3.  Genetic deletion of LXRα prevents arsenic-enhanced atherosclerosis, but not arsenic-altered plaque composition.

Authors:  Maryse Lemaire; Catherine A Lemarié; Manuel Flores Molina; Cynthia Guilbert; Stéphanie Lehoux; Koren K Mann
Journal:  Toxicol Sci       Date:  2014-09-30       Impact factor: 4.849

Review 4.  Impact of prenatal arsenic exposure on chronic adult diseases.

Authors:  Jamie L Young; Lu Cai; J Christopher States
Journal:  Syst Biol Reprod Med       Date:  2018-06-06       Impact factor: 3.061

Review 5.  In utero and early life arsenic exposure in relation to long-term health and disease.

Authors:  Shohreh F Farzan; Margaret R Karagas; Yu Chen
Journal:  Toxicol Appl Pharmacol       Date:  2013-07-13       Impact factor: 4.219

6.  Sodium arsenite delays the differentiation of C2C12 mouse myoblast cells and alters methylation patterns on the transcription factor myogenin.

Authors:  Amanda A Steffens; Gia-Ming Hong; Lisa J Bain
Journal:  Toxicol Appl Pharmacol       Date:  2010-10-18       Impact factor: 4.219

7.  Arsenic exacerbates atherosclerotic lesion formation and inflammation in ApoE-/- mice.

Authors:  Sanjay Srivastava; Elena N Vladykovskaya; Petra Haberzettl; Srinivas D Sithu; Stanley E D'Souza; J Christopher States
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-12       Impact factor: 4.219

Review 8.  Arsenic and cardiovascular disease.

Authors:  J Christopher States; Sanjay Srivastava; Yu Chen; Aaron Barchowsky
Journal:  Toxicol Sci       Date:  2008-11-17       Impact factor: 4.849

Review 9.  Health effects of arsenic and chromium in drinking water: recent human findings.

Authors:  Allan H Smith; Craig M Steinmaus
Journal:  Annu Rev Public Health       Date:  2009       Impact factor: 21.981

10.  Methylation of inorganic arsenic by murine fetal tissue explants.

Authors:  Derrick Broka; Eric Ditzel; Stephanie Quach; Todd D Camenisch
Journal:  Drug Chem Toxicol       Date:  2015-10-07       Impact factor: 3.356

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.